SUPRANE (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the SUPRANE drug offered from Baxter Healthcare Corporation. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: desflurane
SUBSTANCE NAME: DESFLURANE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: General Anesthesia [PE],General Anesthetic [EPC]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1992-09-18
END MARKETING DATE: 0000-00-00


SUPRANE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSUPRANE from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 240(mL/240mL)
START MARKETING DATE: 1992-09-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10019-641_b4793a92-d7a0-4276-b5a5-21ac74a0c0bc
PRODUCT NDC: 10019-641
APPLICATION NUMBER: NDA020118

Other DESFLURANE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationSUPRANE
General Injectables & Vaccines, IncSuprane
Piramal Critical Care IncDesflurane